Clinical Trial

Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
ITM has the potential to be a powerful tool for multimodal postoperative pain management, understanding, preventing and managing its side effects is crucial for upturn of patient safety and comfort. This retrospective audit will therefore be focused on the most reported side effects in daily clinical practice in patients having received ITM. The results of this study may lead to new insights into the clinically relevant risk-benefit balance of ITM and will contribute to the optimisation of its use in clinical practice.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-14.
Trial Details
NCT Number NCT07238179
Lead Sponsor Universitaire Ziekenhuizen KU Leuven
Conditions Morphine, Morphine Adverse Reaction, Morphine Induced Pruritis, Nausea and Vomiting, Postoperative, Analgesia, Spinal Analgesia
Enrollment 600 participants
Start Date 2021-03-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05